On Wednesday 31 March 2021, DESTINA’s Juan Jose Diaz-Mochon will present the First Single Molecule Counting (SMC™) Application with miRNAs by a PCR Free Method. You can register here to watch the presentation https://lnkd.in/eiMknq9
The high specificity of DESTINA technologies has been implemented within the ultrasensitive SMC™ to yield the platform’s first molecular assays. During his presentation, Juan will highlight data from the DESTINA LiverAce™ assay which allows the quantification of miRNA-122 as a biomarker of liver damage.
DESTINA assays stabilise RNA target molecules thanks to its Stabiltech™ Buffer and they are faster than standard PCR based ones as RNA extraction is not needed, hence reducing costs and allowing RNA assays to be run like any other immunoassay in your labs.